Body Composition Analyzers Market Size and Global Forecast to 2031 | Obesity and Preventive Care Fuel Demand for Body Composition Analyzers
Dublin, Oct. 21, 2026 -- "Body Composition Analyzers Market: Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering.
Hospitals & clinics, fitness & wellness centers, academic & research centers, and home users increasingly rely on body composition analyzers for health assessment and performance monitoring. Technological advances in bioelectrical impedance analysis (BIA), combined with integration across digital health platforms and wearable devices, are improving measurement accuracy, connectivity, accessibility, and real-time health tracking. Emerging markets, particularly in Asia Pacific, are expected to provide significant expansion opportunities.
Bioimpedance Analyzers Expected to Record the Highest Growth Rate
Based on product, the bioimpedance analyzers segment is expected to register the highest growth rate between 2026 and 2031. Continuous improvements in bioimpedance technology are enhancing accuracy, reliability, and user-friendliness. Demand is also being strengthened by the increasing use of non-invasive assessments, multifrequency analysis, segmental analysis, and connected health monitoring.
The expansion of fitness and wellness programs, along with growing interest in home-based health monitoring, is supporting broader adoption. Integration with digital health platforms and connected devices enables personalized insights and convenient tracking across clinical, fitness, and consumer applications.
Segmental Body Measurement Held the Largest Market Share in 2025
Based on application, segmental body measurement accounted for the largest share of the body composition analyzers market in 2025. Demand is driven by the need for precise regional assessment of fat distribution, muscle mass, and fluid balance. These capabilities are increasingly important in obesity management, clinical care, sports performance, nutrition planning, and personalized fitness programs.
Advances in multifrequency BIA, octopolar configurations, and digital analytics continue to improve regional measurement capabilities. Compared with whole-body measurements, segmental assessments provide more detailed information for monitoring physical condition, treatment progress, and performance outcomes.
Asia Pacific Positioned as the Fastest-Growing Regional Market
Asia Pacific is expected to post the highest regional growth rate from 2026 to 2031. Rapid urbanization, sedentary lifestyles, dietary changes, rising obesity rates, and increasing incidence of metabolic disorders are contributing to demand for body composition monitoring solutions.
Regional expansion is also supported by greater health and fitness awareness, improving healthcare infrastructure, higher disposable incomes, and the continued development of fitness clubs, wellness programs, and preventive healthcare initiatives. Demand for affordable, portable, and connected analyzers is accelerating adoption across India, China, Japan, and Southeast Asia. Digital health integration is further broadening clinical, fitness, and home-use applications.
Competitive Landscape
Prominent companies operating in the body composition analyzers market include GE HealthCare (US), OMRON Corporation (Japan), Hologic, Inc. (US), InBody Co., Ltd. (South Korea), Tanita Corporation (Japan), seca (Germany), Withings (France), SELVAS Healthcare, Inc. (South Korea), COSMED srl (Italy), and RJL Systems (US). These companies are focusing on product innovation, research & development, connected monitoring capabilities, geographic expansion, and strategic investments to strengthen their market positions.
Primary Research Participant Breakdown
- By Company Type: Tier 1-35%, Tier 2-40%, and Tier 3-25%
- By Designation: Directors-25%, Managers-50%, and Others-25%
- By Region: North America-43%, Europe-14%, Asia Pacific-26%, Latin America- 12%, and the Middle East & Africa- 5%
Research Coverage
The report analyzes the body composition analyzers market by product, usage type, modality, application, end user, and region. It evaluates market drivers, restraints, opportunities, and challenges while examining competitive strategies, product offerings, technology developments, investments, and new product launches. Revenue forecasts are provided for key segments across five major regions and their respective countries.
Key growth drivers include the increasing focus on body fat and muscle mass assessment, wider use of body composition analysis in preventive healthcare, and expansion of fitness, wellness, and sports performance centers. Opportunities are emerging from connected and data-driven monitoring solutions. However, limited reimbursement, measurement sensitivity to hydration status and testing conditions, lack of standardization, and competition from established clinical imaging technologies may restrict adoption.
The report enables established companies, emerging participants, and smaller firms to assess market trends, identify untapped geographic opportunities, evaluate product development priorities, and strengthen their competitive positioning. It also provides insights into market development, diversification strategies, innovation pipelines, regional potential, and the growth approaches adopted by leading industry participants.
| Report Attribute | Details |
| No. of Pages | 341 |
| Forecast Period | 2026 - 2031 |
| Estimated Market Value (USD) in 2026 | $0.99 billion |
| Forecasted Market Value (USD) by 2031 | $1.39 billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
Key Topics Covered:
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN BODY COMPOSITION ANALYZERS MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 BODY COMPOSITION ANALYZERS MARKET OVERVIEW
3.2 EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY END USER AND COUNTRY (2025)
3.3 BODY COMPOSITION ANALYZERS MARKET: REGION (2026?2031)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Rising prevalence of obesity and increasing focus on body fat and muscle mass assessment
4.2.1.2 Growing adoption of body composition analysis in weight management and preventive healthcare
4.2.1.3 Growing geriatric population and rising demand for sarcopenia & muscle mass monitoring
4.2.2 RESTRAINTS
4.2.2.1 Limited reimbursement for routine body composition assessment
4.2.2.2 High sensitivity of bioimpedance measurements to hydration status and measurement conditions
4.2.3 OPPORTUNITIES
4.2.3.1 Increasing establishment of fitness, wellness, and sports performance centers
4.2.3.2 Growing demand for connected and data-driven monitoring
4.2.4 CHALLENGES
4.2.4.1 Lack of standardization across BIA devices, algorithms, and measurement protocols
4.2.4.2 Competition from established clinical imaging technologies such as CT and MRI
4.3 UNMET NEEDS AND WHITE SPACES
4.3.1 UNMET NEEDS IN BODY COMPOSITION ANALYZERS MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
4.5.1 STRATEGIC MOVES IN BODY COMPOSITION ANALYZERS MARKET
5 INDUSTRY TRENDS
5.1 PORTER'S FIVE FORCES ANALYSIS
5.1.1 THREAT FROM NEW ENTRANTS
5.1.2 THREAT FROM SUBSTITUTES
5.1.3 BARGAINING POWER OF SUPPLIERS
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC INDICATORS
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS AND FORECAST
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.5.1 MANUFACTURERS
5.5.2 END USERS
5.5.3 REGULATORY BODIES
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023-2025
5.6.2 AVERAGE SELLING PRICE TREND, BY MODALITY, 2023-2025
5.6.3 AVERAGE SELLING PRICE TREND, BY REGION, 2023-2025
5.7 TRADE ANALYSIS
5.7.1 IMPORT DATA (HS CODE 901819)
5.7.2 EXPORT DATA (HS CODE 901819)
5.7.3 IMPORT DATA (HS CODE 903180)
5.7.4 EXPORT DATA FOR (HS CODE 903180)
5.8 REIMBURSEMENT SCENARIO
5.9 KEY CONFERENCES & EVENTS, 2026-2027
5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.11 INVESTMENT & FUNDING SCENARIO
5.12 CASE STUDY ANALYSIS
5.13 IMPACT OF 2025 US TARIFFS-BODY COMPOSITION ANALYZERS MARKET
5.13.1 INTRODUCTION
5.13.2 KEY TARIFF RATES
5.13.3 PRICE IMPACT ANALYSIS
5.13.4 IMPACT ON COUNTRIES/REGIONS
5.13.5 IMPACT ON END-USE SEGMENTS
5.13.5.1 Hospitals & clinics
5.13.5.2 Fitness clubs & wellness centers
5.13.5.3 Academic & research centers
5.13.5.4 Home Users
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 TECHNOLOGY ANALYSIS
6.1.1 KEY EMERGING TECHNOLOGIES
6.1.1.1 Wearable body composition monitoring
6.1.1.2 AI-enabled body composition analysis and smartphone-based assessment
6.1.2 COMPLEMENTARY TECHNOLOGIES
6.1.2.1 Cloud-based body composition data platforms
6.1.2.2 Digital nutrition and weight-management technologies
6.1.3 ADJACENT TECHNOLOGIES
6.1.3.1 MRI and CT-based body composition analysis
6.1.3.2 Ultrasound body composition assessment
6.2 TECHNOLOGY/PRODUCT ROADMAP
6.2.1 NEAR-TERM (2025-2027)
6.2.2 MID-TERM (2028-2030)
6.2.3 LONG-TERM (2030+)
6.3 PATENT ANALYSIS
6.3.1 JURISDICTION AND TOP APPLICANT ANALYSIS
6.4 FUTURE APPLICATIONS
6.4.1 AI-ASSISTED PERSONALIZED BODY COMPOSITION MANAGEMENT
6.4.2 REMOTE AND HOME-BASED BODY COMPOSITION MONITORING
6.4.3 OBESITY AND WEIGHT-MANAGEMENT APPLICATIONS
6.4.4 SARCOPENIA AND MUSCLE-HEALTH ASSESSMENT
6.5 IMPACT OF AI/GEN AI ON BODY COMPOSITION ANALYZERS
6.5.1 INTRODUCTION
6.5.2 MARKET POTENTIAL OF AI IN BODY COMPOSITION ANALYZERS
6.5.3 AI USE CASES
6.5.4 KEY COMPANIES IMPLEMENTING AI
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
7.1 REGULATORY LANDSCAPE
7.1.1 REGULATORY FRAMEWORK
7.1.1.1 North America
7.1.1.2 Europe
7.1.1.3 Asia Pacific
7.1.1.4 Latin America
7.1.1.5 Middle East & Africa
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.3 INDUSTRY STANDARDS
7.2 SUSTAINABILITY INITIATIVES
7.2.1 REDUCING MEDICAL WASTE & USE OF LOWER-IMPACT MATERIALS AND PACKAGING
7.2.2 WATER, ENERGY, AND RESOURCE EFFICIENCY
7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 KEY STAKEHOLDERS & BUYING CRITERIA
8.2.1 KEY STAKEHOLDERS IN THE BUYING PROCESS
8.2.2 BUYING CRITERIA
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
9 BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT
9.1 INTRODUCTION
9.2 BIOIMPEDANCE ANALYZERS
9.2.1 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS
9.2.1.1 Detailed body water and segmental assessment supporting demand
9.2.1.2 Global volume analysis of multi-frequency bioimpedance analyzers, 2024-2031 (units)
9.2.2 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS
9.2.2.1 Cost-effective assessment expanding accessibility
9.2.2.2 Global volume analysis of single-frequency bioimpedance analyzers, 2024-2031 (units)
9.2.3 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS
9.2.3.1 Enhanced fluid assessment and practical measurement supporting adoption
9.2.3.2 Global volume analysis of dual-frequency bioimpedance analyzers, 2024-2031 (units)
9.3 DUAL-ENERGY X-RAY ABSORPTIOMETRY EQUIPMENT
9.3.1 COMPREHENSIVE BONE AND BODY COMPOSITION ASSESSMENT SUPPORTING ADOPTION
9.4 SKINFOLD CALIPERS
9.4.1 SIMPLE MEASUREMENT OF SUBCUTANEOUS FAT SUPPORTING CONTINUED USE
9.5 AIR DISPLACEMENT PLETHYSMOGRAPHY EQUIPMENT
9.5.1 RAPID ASSESSMENT AND COST-EFFECTIVE TESTING SUPPORTING ADOPTION
9.6 HYDROSTATIC WEIGHING EQUIPMENT
9.6.1 ESTABLISHED BODY DENSITY METHOD SUPPORTING NICHE APPLICATIONS
10 BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE
10.1 INTRODUCTION
10.2 PROFESSIONAL-GRADE BODY COMPOSITION ANALYZERS
10.2.1 EXPANDING FITNESS AND SPECIALIZED ASSESSMENT FACILITIES SUPPORTING DEMAND
10.3 CONSUMER-GRADE BODY COMPOSITION ANALYZERS
10.3.1 ADVANCEMENTS IN CONNECTED AND HOME-BASED MONITORING SUPPORTING GROWTH
11 BODY COMPOSITION ANALYZERS MARKET, BY MODALITY
11.1 INTRODUCTION
11.2 PORTABLE BODY COMPOSITION ANALYZERS
11.2.1 MOBILITY AND WIRELESS DATA CONNECTIVITY SUPPORTING BROADER ADOPTION
11.3 STATIONARY/BENCHTOP BODY COMPOSITION ANALYZERS
11.3.1 STANDARDIZED MEASUREMENT AND PROFESSIONAL-GRADE FEATURES SUPPORTING ADOPTION
12 BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION
12.1 INTRODUCTION
12.2 SEGMENTAL BODY MEASUREMENT
12.2.1 DETAILED REGIONAL ANALYSIS SUPPORTING PERSONALIZED ASSESSMENT
12.3 WHOLE-BODY MEASUREMENT
12.3.1 COMPREHENSIVE BODY COMPOSITION ASSESSMENT SUPPORTING WIDER APPLICATION
13 BODY COMPOSITION ANALYZERS MARKET, BY END USER
13.1 INTRODUCTION
13.2 FITNESS CLUBS & WELLNESS CENTERS
13.2.1 EXPANDING FITNESS INFRASTRUCTURE SUPPORTING DEMAND
13.3 HOSPITALS & CLINICS
13.3.1 OSTEOPOROSIS ASSESSMENT AND CLINICAL BODY COMPOSITION MONITORING SUPPORTING DEMAND
13.4 ACADEMIC & RESEARCH CENTERS
13.4.1 INCREASING RESEARCH FUNDING AND TECHNOLOGY VALIDATION ACTIVITIES SUPPORTING DEMAND
13.5 HOME USERS
13.5.1 CONNECTED AND USER-FRIENDLY DEVICES SUPPORTING HOME-BASED MONITORING
14 BODY COMPOSITION ANALYZERS MARKET, BY REGION
14.1 INTRODUCTION
14.2 NORTH AMERICA
14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
14.2.2 NORTH AMERICA: VOLUME ANALYSIS, 2024-2031 (UNITS)
14.2.3 US
14.2.3.1 High Obesity Prevalence and Growing Need for Direct Body Composition Assessment Driving Market Growth
14.2.4 CANADA
14.2.4.1 Increasing Adiposity and Growing Attention to Abdominal Fat Assessment Supporting Market Growth
14.3 EUROPE
14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
14.3.2 EUROPE: VOLUME ANALYSIS, 2024-2031 (UNITS)
14.3.3 GERMANY
14.3.3.1 Widespread Excess Weight and Rising Demand for More Detailed Body Assessment Supporting Market Growth
14.3.4 FRANCE
14.3.4.1 Growing Clinical Use of Body Composition Assessment in Obesity Care Supporting Market Growth
14.3.5 UK
14.3.5.1 Expansion of Large-Scale Body Composition Research Supporting Demand for Advanced Assessment Technologies
14.3.6 ITALY
14.3.6.1 Growing Adoption of Body Composition Assessment in Obesity Management Supporting Market Expansion
14.3.7 SPAIN
14.3.7.1 Increasing Use of Body Composition Monitoring in Obesity and Metabolic Health Supporting Market Growth
14.3.8 REST OF EUROPE
14.4 ASIA PACIFIC
14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
14.4.2 ASIA PACIFIC: VOLUME ANALYSIS, 2024-2031 (UNITS)
14.4.3 CHINA
14.4.3.1 Rising cases of obesity in children to propel the market
14.4.4 JAPAN
14.4.4.1 Growing Emphasis on Healthy Aging and Muscle Mass Assessment Creating Demand for Body Composition Technologies
14.4.5 INDIA
14.4.5.1 Expanding Obesity Management Initiatives and Greater Focus on Body Fat Assessment Driving Market Growth
14.4.6 AUSTRALIA
14.4.6.1 Use of body composition assessment in high-performance sports to sustain demand
14.4.7 SOUTH KOREA
14.4.7.1 Evolving Obesity Assessment Practices Driving Demand for Body Composition Technologies
14.4.8 REST OF ASIA PACIFIC
14.5 LATIN AMERICA
14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
14.5.2 LATIN AMERICA: VOLUME ANALYSIS, 2024-2031 (UNITS)
14.5.3 BRAZIL
14.5.3.1 Strengthening Obesity Management Practices Creating Opportunities for Body Composition Assessment
14.5.4 MEXICO
14.5.4.1 Increasing Emphasis on Comprehensive Obesity Assessment Creating Opportunities for Body Composition Technologies
14.5.5 REST OF LATIN AMERICA
14.6 MIDDLE EAST & AFRICA
14.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
14.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, 2024-2031 (UNITS)
14.6.3 GCC COUNTRIES
14.6.3.1 Kingdom of Saudi Arabia
14.6.3.1.1 Expanding weight management programs creating opportunities for body composition assessment
14.6.3.2 UAE
14.6.3.2.1 Rising emphasis on obesity prevention and weight management to propel market
14.6.4 REST OF GCC COUNTRIES
14.6.5 REST OF MIDDLE EAST & AFRICA
15 COMPETITIVE LANDSCAPE
15.1 OVERVIEW
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
15.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE BODY COMPOSITION ANALYZERS MARKET
15.3 REVENUE ANALYSIS
15.4 MARKET SHARE ANALYSIS
15.4.1 GLOBAL BODY COMPOSITION ANALYZERS MARKET SHARE ANALYSIS, 2025
15.4.2 US BODY COMPOSITION ANALYZERS MARKET SHARE ANALYSIS, 2025
15.4.3 EUROPE BODY COMPOSITION ANALYZERS MARKET SHARE ANALYSIS, 2025
15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
15.5.1 STARS
15.5.2 EMERGING LEADERS
15.5.3 PERVASIVE PLAYERS
15.5.4 PARTICIPANTS
15.6 COMPANY FOOTPRINT
15.6.1 COMPANY FOOTPRINT: KEY PLAYERS, 2025
15.6.1.1 Company footprint
15.6.1.2 Region footprint
15.6.1.3 Product footprint
15.6.1.4 Modality footprint
15.6.1.5 Usage type footprint
15.6.1.6 Application footprint
15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
15.7.1 PROGRESSIVE COMPANIES
15.7.2 RESPONSIVE COMPANIES
15.7.3 DYNAMIC COMPANIES
15.7.4 STARTING BLOCKS
15.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
15.7.5.1 Detailed list of key startups/SMEs
15.7.5.2 Competitive benchmarking of key startups/SMEs
15.8 COMPANY VALUATION & FINANCIAL METRICS
15.8.1 FINANCIAL METRICS
15.8.2 COMPANY VALUATION
15.9 BRAND/PRODUCT COMPARISON
15.10 COMPETITIVE SCENARIO
15.10.1 PRODUCT LAUNCHES & APPROVALS
15.10.2 DEALS
15.10.3 EXPANSIONS
15.10.4 OTHER DEVELOPMENTS
16 COMPANY PROFILES
16.1 KEY PLAYERS
16.1.1 GE HEALTHCARE
16.1.1.1 Business overview
16.1.1.2 Products offered
16.1.1.3 Recent developments
16.1.1.3.1 Deals
16.1.1.4 Analyst's view
16.1.1.4.1 Key strengths/Right to win
16.1.1.4.2 Strategic choices
16.1.1.4.3 Weaknesses & competitive threats
16.1.2 OMRON CORPORATION
16.1.2.1 Business overview
16.1.2.2 Products offered
16.1.2.3 Recent developments
16.1.2.3.1 Deals
16.1.2.3.2 Expansions
16.1.2.4 Analyst's view
16.1.2.4.1 Key strengths/Right to win
16.1.2.4.2 Strategic choices
16.1.2.4.3 Weaknesses & competitive threats
16.1.3 HOLOGIC, INC.
16.1.3.1 Business overview
16.1.3.2 Products offered
16.1.3.3 Recent developments
16.1.3.3.1 Deals
16.1.3.4 Analyst's view
16.1.3.4.1 Key strengths/Right to win
16.1.3.4.2 Strategic choices
16.1.3.4.3 Weaknesses & competitive threats
16.1.4 INBODY CO., LTD.
16.1.4.1 Business overview
16.1.4.2 Products offered
16.1.4.3 Recent developments
16.1.4.3.1 Product launches & approvals
16.1.4.3.2 Expansions
16.1.4.4 Analyst's view
16.1.4.4.1 Key strengths/Right to win
16.1.4.4.2 Strategic choices
16.1.4.4.3 Weaknesses & competitive threats
16.1.5 SELVAS HEALTHCARE, INC.
16.1.5.1 Business overview
16.1.5.2 Products offered
16.1.5.3 Recent developments
16.1.5.3.1 Other developments
16.1.6 IMPEDIMED LIMITED
16.1.6.1 Business overview
16.1.6.2 Products offered
16.1.7 DMS IMAGING
16.1.7.1 Business overview
16.1.7.2 Products offered
16.1.7.3 Recent developments
16.1.7.3.1 Product launches & approvals
16.1.7.3.2 Deals
16.1.8 A&D COMPANY, LIMITED
16.1.8.1 Business overview
16.1.8.2 Products offered
16.1.8.3 Recent developments
16.1.8.3.1 Deals
16.1.9 XIAOMI CORPORATION
16.1.9.1 Business overview
16.1.9.2 Products offered
16.1.9.3 Recent developments
16.1.9.3.1 Product launches & approvals
16.1.10 TANITA CORPORATION
16.1.10.1 Business overview
16.1.10.2 Products offered
16.1.10.3 Recent developments
16.1.10.3.1 Product launches & approvals
16.1.10.3.2 Deals
16.1.11 SECA
16.1.11.1 Business overview
16.1.11.2 Products offered
16.1.11.3 Recent developments
16.1.11.3.1 Product launches
16.1.11.3.2 Deals
16.1.12 WITHINGS
16.1.12.1 Business overview
16.1.12.2 Products offered
16.1.12.3 Recent developments
16.1.12.3.1 Product & services launches
16.1.12.3.2 Deals
16.1.13 COSMED S.R.L.
16.1.13.1 Business overview
16.1.13.2 Products offered
16.1.13.3 Recent developments
16.1.13.3.1 Deals
16.1.14 RJL SYSTEMS
16.1.14.1 Business overview
16.1.14.2 Products offered
16.1.15 CHARDER ELECTRONIC CO., LTD.
16.1.15.1 Business overview
16.1.15.2 Products offered
16.1.15.3 Recent developments
16.1.15.3.1 Other developments
16.1.16 BODYSTAT LIMITED
16.1.16.1 Business overview
16.1.16.2 Products offered
16.2 OTHER PLAYERS
16.2.1 MALTRON INTERNATIONAL LTD.
16.2.2 AKERN S.R.L.
16.2.3 BIOTEKNA
16.2.4 BIODYNAMICS CORPORATION
16.2.5 MICROLIFE CORPORATION
16.2.6 NUMED S.A.R.L.
16.2.7 TONGYONG TIZHI HEALTH TECHNOLOGY CO., LTD.
16.2.8 FOOK TIN TECHNOLOGIES LTD.
16.2.9 OSTEOSYS CORP.
16.2.10 EXERTECH
16.2.11 SHANGHAI GOLDENWELL MEDICAL TECHNOLOGY CO., LTD.
17 RESEARCH METHODOLOGY
17.1 RESEARCH DATA
17.1.1 SECONDARY DATA
17.1.1.1 Key secondary sources
17.1.2 PRIMARY DATA
17.1.2.1 Primary sources
17.1.2.2 Key data from primary sources
17.1.2.3 Key industry insights
17.1.2.4 Breakdown of primaries
17.2 MARKET SIZE ESTIMATION
17.2.1 APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH
17.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
17.2.3 APPROACH 3: TOP-DOWN APPROACH
17.2.4 APPROACH 4: BOTTOM-UP APPROACH
17.2.5 APPROACH 5: PRIMARY INTERVIEWS
17.2.6 APPROACH 6: DEMAND-SIDE APPROACH
17.2.7 APPROACH 7: VOLUME DATA ANALYSIS
17.3 DATA TRIANGULATION AND MARKET BREAKDOWN
17.4 MARKET SHARE ASSESSMENT
17.5 RESEARCH ASSUMPTIONS
17.5.1 STUDY ASSUMPTIONS
17.5.2 GROWTH RATE ASSUMPTIONS
17.6 RISK ASSESSMENT
17.6.1 RESEARCH LIMITATIONS
18 APPENDIX
18.1 DISCUSSION GUIDE
18.2 KNOWLEDGESTORE: THE SUBSCRIPTION PORTAL
18.3 CUSTOMIZATION OPTIONS
18.3.1 PRODUCT ANALYSIS
18.3.2 COMPANY INFORMATION
18.3.3 GEOGRAPHIC ANALYSIS
18.4 RELATED REPORTS
18.5 AUTHOR DETAILS
List of Tables [341]
List of Figures [58]
For more information about this report visit https://www.researchandmarkets.com/r/umyft4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.